Impact of pregnancy on the clinical activity of Crohn's disease

Aliment Pharmacol Ther. 2005 Mar 1;21(5):509-13. doi: 10.1111/j.1365-2036.2005.02384.x.

Abstract

Background: The impact of pregnancy on Crohn's disease activity has been poorly investigated.

Aim: To determine the effect of pregnancy on Crohn's disease activity from the retrospective analysis of a cohort of women who had a regular clinical follow-up.

Methods: Seventy pregnancies occurring in 61 women were studied. The Harvey-Bradshaw index was determined during the four quarters preceding each pregnancy, the three quarters of pregnancy and the four quarters following delivery.

Results: The mean Harvey-Bradshaw index during pregnancy [0.68 (0.18), mean (S.E.M.)] was significantly lower than that of the year preceding pregnancy [0.98 (0.16), P = 0.03] and that of the year following delivery [1.10 (0.17), P = 0.04]. In non-smoking women (48 pregnancies), there was no significant change of Harvey-Bradshaw index between these intervals. Whereas in those who smoked (22 pregnancies), most of whom reduced tobacco consumption during pregnancy, the mean Harvey-Bradshaw index during pregnancy was significantly reduced compared with that of the year following delivery [0.58 (0.20) vs. 1.60 (0.33), P = 0.01]. The use of drugs was significantly lower during pregnancy.

Conclusions: Crohn's disease activity is mildly but significantly lower during pregnancy. The reduction of tobacco consumption during pregnancy in smoking women may play an important role in this improvement.

MeSH terms

  • Adult
  • Cohort Studies
  • Crohn Disease / drug therapy
  • Crohn Disease / etiology*
  • Crohn Disease / surgery
  • Female
  • Humans
  • Infant, Newborn
  • Male
  • Pregnancy
  • Pregnancy Complications / drug therapy
  • Pregnancy Complications / etiology*
  • Pregnancy Complications / surgery
  • Pregnancy Outcome
  • Retrospective Studies